U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07460882) titled 'The Impact of Low Sodium Salt Substitute Use on Serum Potassium Levels Among Patients With Hypertension' on March 05.
Brief Summary: The goal of this pre-post study is to assess the risk of hyperkalemia in adults with hypertension on medication in Bangladesh. The main questions it aims to answer are:
Is the risk of hyperkalemia after the initiation of Low Sodium Salt Substitute (LSSS) in people on antihypertensive medication (especially RASi) large enough to be concerned about its broad use in this population?
Does initiation of LSSS correct hypokalemia in people on antihypertensive medication (especially RASi) with low serum pot...